• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用液质联用技术对临床前人类 CAR T 细胞进行高维功能表型分析。

High-dimensional functional phenotyping of preclinical human CAR T cells using mass cytometry.

机构信息

Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, Zayed Centre For Research into Rare Disease in Children, WC1N 1DZ London, UK.

Cell Communication Lab, Department of Oncology, University College London Cancer Institute, WC1E 6DD London, UK.

出版信息

STAR Protoc. 2022 Feb 9;3(1):101174. doi: 10.1016/j.xpro.2022.101174. eCollection 2022 Mar 18.

DOI:10.1016/j.xpro.2022.101174
PMID:35199038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8844283/
Abstract

Here, we present a comprehensive protocol for the generation and functional characterization of chimeric antigen receptor (CAR) T cells and their products by mass cytometry in a reproducible and scalable manner. We describe the production of CAR T cells from human peripheral blood mononuclear cells. We then detail a three-step staining protocol with metal-labeled antibodies and the subsequent mass cytometry analysis. This protocol allows simultaneous characterization of CAR T cell intracellular signaling, activation, proliferation, cytokine production, and phenotype in a single assay.

摘要

在这里,我们提供了一个全面的协议,用于通过质量细胞术以可重复和可扩展的方式生成和功能表征嵌合抗原受体 (CAR) T 细胞及其产物。我们描述了从人外周血单核细胞中生产 CAR T 细胞的过程。然后,我们详细介绍了一个三步染色方案,使用金属标记的抗体,以及随后的质量细胞术分析。该方案允许在单个测定中同时表征 CAR T 细胞的细胞内信号转导、激活、增殖、细胞因子产生和表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/d505b4be17a3/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/7aa4b2ada717/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/cdf82d517e3f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/a5da964c71db/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/9964b89b91b5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/740c38ad5777/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/0e4ada06c48d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/021770ecb818/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/899f624b87c5/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/69d3c94a2de2/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/d505b4be17a3/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/7aa4b2ada717/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/cdf82d517e3f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/a5da964c71db/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/9964b89b91b5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/740c38ad5777/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/0e4ada06c48d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/021770ecb818/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/899f624b87c5/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/69d3c94a2de2/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6f/8844283/d505b4be17a3/gr9.jpg

相似文献

1
High-dimensional functional phenotyping of preclinical human CAR T cells using mass cytometry.使用液质联用技术对临床前人类 CAR T 细胞进行高维功能表型分析。
STAR Protoc. 2022 Feb 9;3(1):101174. doi: 10.1016/j.xpro.2022.101174. eCollection 2022 Mar 18.
2
Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.不同的细胞因子和刺激条件会影响针对肿瘤抗原GD2的第三代嵌合抗原受体T细胞的扩增和免疫表型。
Cytotherapy. 2015 Apr;17(4):487-95. doi: 10.1016/j.jcyt.2014.12.002. Epub 2015 Jan 6.
3
A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count.一种简单有效的方法,用于从高单核细胞计数的患者中成功地纯化和激活 T 细胞,以生成嵌合抗原受体 T(CAR-T)细胞。
J Transl Med. 2022 Dec 19;20(1):608. doi: 10.1186/s12967-022-03833-6.
4
High-throughput mass cytometry staining for deep phenotyping of human natural killer cells.高通量液质细胞术染色法对人自然杀伤细胞进行深度表型分析。
STAR Protoc. 2022 Dec 16;3(4):101768. doi: 10.1016/j.xpro.2022.101768. Epub 2022 Oct 20.
5
A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors.一种用于检测抗 CD19 嵌合抗原受体的 CD19/Fc 融合蛋白。
J Transl Med. 2013 Jan 29;11:23. doi: 10.1186/1479-5876-11-23.
6
Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol.用于化疗复发或难治性急性淋巴细胞白血病的第三代CD28/4-1BB嵌合抗原受体T细胞:一项非随机、开放标签的I期试验方案
BMJ Open. 2016 Dec 30;6(12):e013904. doi: 10.1136/bmjopen-2016-013904.
7
An In Vitro Model to Assess CRS Potential of CAR T Cells Using a Tumor Cell Line and Autologous Monocytes.利用肿瘤细胞系和自体单核细胞评估 CAR T 细胞 CRS 潜力的体外模型。
Curr Protoc. 2023 Aug;3(8):e864. doi: 10.1002/cpz1.864.
8
Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T.胎盘循环 T 细胞:与成人 PBMC 来源的 CAR-T 相比,新型同种异体 CAR-T 细胞平台具有保留的 T 细胞干性、更有利的细胞因子谱和持久的疗效。
J Immunother Cancer. 2024 Apr 29;12(4):e008656. doi: 10.1136/jitc-2023-008656.
9
Measuring Chimeric Antigen Receptor T Cells (CAR T Cells) Activation by Coupling Intracellular Cytokine Staining with Flow Cytometry.通过流式细胞术检测细胞内细胞因子染色来测量嵌合抗原受体 T 细胞 (CAR T 细胞) 的激活。
Methods Mol Biol. 2020;2108:159-165. doi: 10.1007/978-1-0716-0247-8_14.
10
functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma.表达赖氨酸特异性去甲基化酶1短发夹RNA的抗CD19嵌合抗原受体T细胞治疗弥漫性大B细胞淋巴瘤的功能验证
Front Immunol. 2025 Jan 13;15:1521778. doi: 10.3389/fimmu.2024.1521778. eCollection 2024.

引用本文的文献

1
CyTOF as a suitable tool for stratification and monitoring of cancer patients.质谱流式细胞术作为一种适用于癌症患者分层和监测的工具。
J Transl Med. 2025 Jul 1;23(1):724. doi: 10.1186/s12967-025-06764-0.
2
New insights on potency assays from recent advances and discoveries in CAR T-cell therapy.嵌合抗原受体T细胞(CAR T)疗法的最新进展与发现为效力测定带来的新见解。
Front Immunol. 2025 May 8;16:1597888. doi: 10.3389/fimmu.2025.1597888. eCollection 2025.
3
Enhanced efficacy of dual chimeric antigen receptor-T cells targeting programmed death-ligand 1 and cancer-associated fibroblasts in colorectal cancer .

本文引用的文献

1
Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies.质谱流式细胞术:用于嵌合抗原受体T细胞疗法全面免疫监测的强大平台。
Br J Haematol. 2021 Aug;194(4):788-792. doi: 10.1111/bjh.17551. Epub 2021 May 26.
2
Enriching leukapheresis improves T cell activation and transduction efficiency during CAR T processing.在嵌合抗原受体T细胞(CAR T)处理过程中,富集白细胞分离术可提高T细胞活化和转导效率。
Mol Ther Methods Clin Dev. 2021 Feb 6;20:675-687. doi: 10.1016/j.omtm.2021.02.002. eCollection 2021 Mar 12.
3
Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity.
靶向程序性死亡配体1和癌症相关成纤维细胞的双嵌合抗原受体T细胞在结直肠癌中的疗效增强
Cytojournal. 2025 Mar 6;22:29. doi: 10.25259/Cytojournal_245_2024. eCollection 2025.
4
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.淋巴耗竭后用于晚期肉瘤的自体 HER2 特异性 CAR T 细胞:一项 1 期试验。
Nat Cancer. 2024 Jun;5(6):880-894. doi: 10.1038/s43018-024-00749-6. Epub 2024 Apr 24.
5
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells.激活启动和细胞因子多功能性调节低亲和力 CD19 CAR T 细胞的增强功能。
Blood Adv. 2023 May 9;7(9):1725-1738. doi: 10.1182/bloodadvances.2022008490.
测量CAR T细胞介导的细胞毒性的检测方法的比较分析。
Nat Protoc. 2021 Mar;16(3):1331-1342. doi: 10.1038/s41596-020-00467-0. Epub 2021 Feb 15.
4
Automated Data Cleanup for Mass Cytometry.质谱流式细胞术的自动化数据清理
Cytometry A. 2020 Feb;97(2):184-198. doi: 10.1002/cyto.a.23926. Epub 2019 Nov 18.
5
Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.工程化 γδT 细胞限制嵌合抗原受体相关的 tonic 信号。
Sci Signal. 2019 Sep 10;12(598):eaax1872. doi: 10.1126/scisignal.aax1872.
6
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.低亲和力 CD19 CAR 治疗儿童 ALL 患者可增强 CAR T 细胞扩增和延长持久性。
Nat Med. 2019 Sep;25(9):1408-1414. doi: 10.1038/s41591-019-0549-5. Epub 2019 Sep 2.
7
Development of a Comprehensive Antibody Staining Database Using a Standardized Analytics Pipeline.利用标准化分析流程开发全面的抗体染色数据库。
Front Immunol. 2019 Jun 11;10:1315. doi: 10.3389/fimmu.2019.01315. eCollection 2019.
8
Acquisition, Processing, and Quality Control of Mass Cytometry Data.质谱流式细胞术数据的采集、处理与质量控制
Methods Mol Biol. 2019;1989:13-31. doi: 10.1007/978-1-4939-9454-0_2.
9
Stabilizing Antibody Cocktails for Mass Cytometry.用于质谱细胞术的稳定抗体鸡尾酒。
Cytometry A. 2019 Aug;95(8):910-916. doi: 10.1002/cyto.a.23781. Epub 2019 May 6.
10
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape.嵌合抗原受体 T 细胞 trogocytosis 和协同杀伤调节肿瘤抗原逃逸。
Nature. 2019 Apr;568(7750):112-116. doi: 10.1038/s41586-019-1054-1. Epub 2019 Mar 27.